hotspot -WSS

hotspot

author：knowledge 2025-10-01 23:58:15 - browse：2

Sen. Bernie Sanders, I-Vt., chairman of the Senate Health, Education, Labor, and Pensions Committee listens during a hearing on Capitol Hill in Washington – politics and policy coverage from STAT — Senate health committee Chair Bernie Sanders (I-Vt.) wants to reward new medicines with prize money. Jose Luis Magana/AP

WASHINGTON — Sen. Bernie Sanders (I-Vt.) will finally get a study of his proposal to do away with drug patents and other intellectual property protections in favor of rewarding inventions with prize money. Sanders has been pushing the prize approach since he was a House representative, many years ago.

The measure directing the National Academies of Sciences, Engineering and Medicine to study the idea was added to the Pandemic All-Hazards and Preparedness Act a day before Sander’s health committee passed the bill. Three Republicans voted against the overall bill, which renews several federal biodefense and pandemic-preparedness programs.

Though Democrats last year passed historic legislation to let Medicare negotiate drug prices and cap seniors’ annual out-of-pocket drug costs, Sanders is demanding more drug price controls. He is delaying President Biden’s pick for running the National Institutes of Health until the president releases a plan to control drug prices.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical records are filled with copy
Next article： Achieving telehealth equity for people with hearing loss

WSS

The Biogen Aduhelm mess could happen again

J&J reports mixed data on next

Unique patient identifier: Experts argue the benefits, pitfalls

Updated Covid vaccine has 54% effectiveness, new study suggests

Achieving telehealth equity for people with hearing loss

Readout LOUD: Venture capital, Gilead, and more M&A

focus

hotspot

hotspot

Malaria cases in Florida and Texas: Here’s what you need to know

Johnson & Johnson sued for allegedly overpaying for workers' drugs

The cancer drug shortage isn’t new — and neither are the solutions

Asahi Kasei to buy Calliditas, picking up kidney disease drug

Novavax promises a turnaround & Lilly roils the obesity market

Some medical students still think black patients feel less pain

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

New research sheds light on how often breast cancer is overdiagnosed

Trump demands the U.S. pay no more for drugs than other countries … again

U.S. death rates show how politics are affecting public health

focus

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

Why we need mandatory labeling of GMO products

New research sheds light on how often breast cancer is overdiagnosed

Devoted Health’s losses in Medicare Advantage persist

Some medical students still think black patients feel less pain

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

focus

leisure time

focus

focus